亿帆医药：公司始终坚持“创新与国际化”中长期规划，未来将更加聚焦现有合成生物及医药领域

Group 1 - The company, Yifan Pharmaceutical (002019), emphasizes its commitment to a long-term strategy focused on "innovation and internationalization" [1] - The company plans to concentrate more on its existing synthetic biology and pharmaceutical sectors in the future [1]